rs7439326
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001074.4(UGT2B7):c.722-78T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.495 in 1,524,446 control chromosomes in the GnomAD database, including 193,218 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).
Frequency
Genomes: 𝑓 0.58 ( 26190 hom., cov: 31)
Exomes 𝑓: 0.49 ( 167028 hom. )
Consequence
UGT2B7
NM_001074.4 intron
NM_001074.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.382
Genes affected
UGT2B7 (HGNC:12554): (UDP glucuronosyltransferase family 2 member B7) The protein encoded by this gene belongs to the UDP-glycosyltransferase (UGT) family. UGTs serve a major role in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This protein is localized in the microsome membrane, and has unique specificity for 3,4-catechol estrogens and estriol, suggesting that it may play an important role in regulating the level and activity of these potent estrogen metabolites. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.706 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UGT2B7 | NM_001074.4 | c.722-78T>C | intron_variant | ENST00000305231.12 | NP_001065.2 | |||
UGT2B7 | NM_001330719.2 | c.722-78T>C | intron_variant | NP_001317648.1 | ||||
UGT2B7 | NM_001349568.2 | c.-26-78T>C | intron_variant | NP_001336497.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UGT2B7 | ENST00000305231.12 | c.722-78T>C | intron_variant | 1 | NM_001074.4 | ENSP00000304811.7 |
Frequencies
GnomAD3 genomes AF: 0.576 AC: 87249AN: 151346Hom.: 26144 Cov.: 31
GnomAD3 genomes
AF:
AC:
87249
AN:
151346
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.487 AC: 667958AN: 1372982Hom.: 167028 AF XY: 0.488 AC XY: 331909AN XY: 680806
GnomAD4 exome
AF:
AC:
667958
AN:
1372982
Hom.:
AF XY:
AC XY:
331909
AN XY:
680806
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.577 AC: 87350AN: 151464Hom.: 26190 Cov.: 31 AF XY: 0.585 AC XY: 43310AN XY: 73976
GnomAD4 genome
AF:
AC:
87350
AN:
151464
Hom.:
Cov.:
31
AF XY:
AC XY:
43310
AN XY:
73976
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2274
AN:
3476
ClinVar
Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Tramadol response Other:1
drug response, no assertion criteria provided | research | Bruce Budowle Laboratory, University of North Texas Health Science Center | Apr 28, 2018 | - T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1 |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at